Generation of allogeneic CAR-T circumvents functional deficits in patientderived autologous product for glioblastoma

被引：0
|
作者：
Shaikh, Muhammad Vaseem
Salim, Sabra K.
Wei, Jeffrey
Maich, William T.
Anand, Alisha A.
Tang, Oliver Young
Subapanditha, Minomi K.
Suk, Yujin
Singh, Manoj
Alizada, Zahra
Brakel, Benjamin
Dimitrov, Vassil
Tabunshchyk, Zoya
Brown, Kevin
Vora, Parvez
Binder, Zev
Venugopal, Chitra
Moffat, Jason
Singh, Sheila K.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5241
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Optimization of lymphapheresis for manufacturing autologous CAR-T cells
    Yamanaka, Ikumi
    Yamauchi, Takuji
    Henzan, Tomoko
    Sakoda, Teppei
    Miyamoto, Kyoko
    Mishima, Hiroyuki
    Ono, Hiroaki
    Koga, Yuhki
    Nakashima, Yasuhiro
    Kato, Koji
    Miyamoto, Toshihiro
    Mizuno, Shinichi
    Ogawa, Yoshihiro
    Ohga, Shouichi
    Akashi, Koichi
    Maeda, Takahiro
    Kunisaki, Yuya
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (04) : 449 - 458
  • [22] Allogeneic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T Cell Malignancies
    Zhang, Yinqiang
    Li, Chenggong
    Jiang, Huiwen
    Luo, Wenjing
    Du, Mengyi
    Zhou, Fen
    Tang, Lu
    Wu, Jianghua
    Wei, Qiuzhe
    Lu, Cong
    Kou, Haiming
    Wu, Di
    Alex, Chang H.
    Mei, Heng
    Hu, Yu
    BLOOD, 2022, 140 : 4592 - 4594
  • [23] Generation of CAR-TSCM: CAR-T with super clutch
    Hu, Jinhui
    Liu, Xiang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 136
  • [24] Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development
    Tang, Lin
    Pan, Sheng
    Wei, Xuyong
    Xu, Xiao
    Wei, Qiang
    MOLECULAR THERAPY, 2023, 31 (11) : 3146 - 3162
  • [25] Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant
    Sidana, Surbhi
    Dueck, Amylou C.
    Thanarajasingam, Gita
    Griffin, Joan M.
    Thompson, Carrie
    Durani, Urshila
    Burtis, Michelle
    Warsame, Rahma
    Paludo, Jonas
    Gertz, Morie A.
    Dispenzieri, Angela
    Ansell, Stephen M.
    Rajkumar, S. Vincent
    Yost, Kathleen
    Bennani, Nora
    Lin, Yi
    Kumar, Shaji
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (08): : 473 - 482
  • [26] Recent updates on allogeneic CAR-T cells in hematological malignancies
    Mansoori, Shafieeh
    Noei, Ahmad
    Maali, Amirhosein
    Seyed-Motahari, Seyedeh Sheila
    Sharifzadeh, Zahra
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [27] Improvement of "off-the-shelf'' allogeneic CAR-T cells
    Pavlovic, K.
    Carmona, M. D.
    Maldonado, N.
    Tristan, M.
    Cortijo, M.
    Nogueras, S.
    Jimenez, R.
    Martin, F.
    Herrera, I. C.
    Benabdellah, K.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A87 - A87
  • [28] Overcoming heterogeneous glioblastoma with armored CAR-T cell therapy
    Clubb, Justin D.
    Shih, Ryan
    Gao, Torahito
    Shafer, Amanda
    Vajragiri, Shreya
    Talluri, Sohan
    Bouren, Amber
    Brown, Christine E.
    Okada, Hideho
    Nathanson, David
    Chen, Yvonne
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [29] Design and Characterization of Next-Generation SMAR Nanovectors for Stable Cell Modification: Towards Safer Allogeneic and Autologous Adoptive CAR-T Cell Therapy
    Tasgin, Toros
    Peterson, Julia D.
    De Roia, Alice
    Hartley, Anna
    Burger, Luisa
    Derigs, Patrick
    Harbottle, Richard P.
    MOLECULAR THERAPY, 2024, 32 (04) : 649 - 650
  • [30] LCK KNOCKOUT CAR-T CELLS AS A NOVEL ALLOGENEIC PLATFORM
    Vale, Previtha Dawn Sakthi
    Wu, Ling
    Tan, Vivian Jia Yi
    Chua, Benson
    Wu, Liangzhe
    Tan, Jia Chi
    Koh, Clara Kai Ting
    Ong, June
    Gascoigne, Nicholas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A289 - A289
12345